Molsentech is an innovative company centered on Bio-Nano Silicon Field-Effect Transistor (Bio-FET) technology. It focuses on developing a new generation of highly sensitive, real-time, and label-free biosensing platforms. The company is dedicated to introducing semiconductor technology into the fields of medical diagnostics and precision health, aiming to overcome the limitations of traditional detection methods in terms of speed and sensitivity, and to revolutionize early disease diagnosis and health monitoring.
Molsentech’s Bio-FET semiconductor biomedical chips and detection instruments integrate interdisciplinary technologies including IC design, microfluidic heterogeneous packaging, chemical surface modification, and high-throughput data processing. Bio-FET’s semiconductor biochip platform can instantly detect molecular targets such as nucleic acids, antibodies, antigens, and environmental chemicals in simply processed samples. It directly converts the molecular-probe binding reactions into electrical signals.
The detection process requires no fluorescent labeling or nucleic acid amplification, offering simple operation and extremely high sensitivity. This enables accurate and rapid early disease detection, addressing issues of inaccuracy or failure in early diagnostic testing, and setting a new chapter for clinical diagnostics.